MENU
+Compare
BMNDF
Stock ticker: OTC
AS OF
Jun 25 closing price
Price
$0.10
Change
-$0.00 (-0.00%)
Capitalization
7.75M

BMNDF BIOMIND LABS INC. Forecast, Technical & Fundamental Analysis

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions... Show more

BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMNDF with price predictions
Aug 11, 2025

BMNDF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BMNDF turned positive on July 08, 2025. Looking at past instances where BMNDF's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Aroon Indicator for BMNDF entered a downward trend on July 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.461). P/E Ratio (0.000) is within average values for comparable stocks, (53.401). BMNDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.822). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.886).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BMNDF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Camino Saravia s/n
Phone
+589 92251500
Employees
5
Web
https://www.biomindlabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPAD1.240.08
+6.90%
Offerpad Solutions
AMG214.022.72
+1.29%
Affiliated Managers Group
ISRG471.851.77
+0.38%
Intuitive Surgical
PRA23.940.03
+0.13%
ProAssurance Corp
FET21.89-0.11
-0.48%
Forum Energy Technologies

BMNDF and Stocks

Correlation & Price change

A.I.dvisor tells us that BMNDF and CLVLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and CLVLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
CLVLY - BMNDF
26%
Poorly correlated
-1.15%
MLLCF - BMNDF
21%
Poorly correlated
N/A
VIGL - BMNDF
20%
Poorly correlated
N/A
CYDY - BMNDF
12%
Poorly correlated
-6.84%
BSEM - BMNDF
11%
Poorly correlated
-2.90%
More